Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alain Dutilleul1, Jacques Morel2, Clémentine Schilte3

  • 1Sanofi France, 69007 Lyon, France.

Therapie
|January 8, 2019
PubMed
Summary

No abstract available in PubMed .

Keywords:
Entretien motivationnelHésitation vaccinaleSystèmes d’informationVaccinsÉducation

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stability and prognostic value of B-cell markers in primary SS: results from the French ASSESS cohort.

Rheumatology (Oxford, England)·2026
Same author

One-month delay in MTX initiation on RA outcomes: 1-year ancillary analysis of the VACIMRA trial.

Rheumatology (Oxford, England)·2026
Same author

Accuracy of VIDAS<sup>Ⓡ</sup> TB-IGRA in TB patients and individuals with different thresholds of exposure.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2025
Same author

Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial.

The Lancet. Rheumatology·2025
Same author

Polypharmacy in Early Rheumatoid Arthritis: Impact on Treatment Response and Adverse Event Risk in a multicenter French prospective cohort study.

ACR open rheumatology·2025
Same author

Adaptive immune responses to SARS-CoV-2 in DMARD-treated patients with chronic inflammatory rheumatisms.

RMD open·2025